The results of two randomised trials reported this week in The Lancet give great encouragement to the view that a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be produced within the next 18 months. There are no guarantees. But the evidence is hopeful. Pedro Folegatti and colleagues from The Jenner Institute at the University of Oxford used a chimpanzee…
Our findings support calls to lower or remove the lower limit of current IOM recommendations for pregnant women with obesity, and suggest that separate guidelines…
Chronic suppurative otitis media (CSOM) is a leading global cause of potentially preventable hearing loss in children and adults, associated with socioeconomic deprivation. There is…
However, revisions to the International Health Regulations concerning equitable access and financial assistance are linked to troubled parallel talks on a pandemic accord. By John…
Join us as Commission authors and special guests discuss a new report on breast cancer published in The Lancet.
Outcomes following anaesthesia and surgery for children in Africa are poor, with complication rates up to four-fold higher (18% vs 4·4–14%) and mortality rates 11-fold…
Despite tremendous advances in breast cancer research and treatment over the past t hree decades—leading to a reduction in breast cancer mortality of over 40%…
Join us as Commission authors and special guests discuss a new report on breast cancer published in The Lancet.
A 67-year-old woman was referred to our department for investigation of a 3-year history of declining renal function—serum creatinine concentration was 1·2 mg/dL (typical range…
WHO has determined a public health emergency of international concern (PHEIC) seven times, and beyond this nomenclature declared COVID-19 to be a pandemic. Under the…
A 78-year-old man with primary central nervous system lymphoma was started on rituximab, methotrexate, and corticosteroids. Baseline hepatitis B virus (HBV) serologic tests, 2 months…
